Loading clinical trials...
Loading clinical trials...
Ozurdex as Monotherapy for Treatment of Non-infectious Intermediate, Posterior, or Panuveitis
Conditions
Interventions
Ozurdex 0.7mg Ophthalmic Implant
Prednisone
Locations
1
Canada
Ottawa Hospital Research Institute - Vision Research Centre
Ottawa, Ontario, Canada
Start Date
November 30, 2021
Primary Completion Date
January 15, 2025
Completion Date
January 15, 2025
Last Updated
March 12, 2025
NCT05486468
NCT06431373
NCT01280669
NCT06085079
NCT03097315
NCT02952001
Lead Sponsor
Ottawa Hospital Research Institute
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions